Mix and match - A comprehensive pipeline for matched patient-derived PDX and PD3D® modelsfor cancer research and preclinical drug development

被引:1
|
作者
Loskutov, Jurgen
Oswald, Eva
Reinhard, Christoph J.
Schueler, Julia
Regenbrecht, Christian R.
机构
关键词
D O I
10.1158/1538-7445.AM2024-240
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
240
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Prediction of Patient Drug Response via 3D Bioprinted Gastric Cancer Model Utilized Patient-Derived Tissue Laden Tissue-Specific Bioink
    Choi, Yoo-mi
    Na, Deukchae
    Yoon, Goeun
    Kim, Jisoo
    Min, Seoyeon
    Yi, Hee-Gyeong
    Cho, Soo-Jeong
    Cho, Jae Hee
    Lee, Charles
    Jang, Jinah
    ADVANCED SCIENCE, 2025,
  • [42] Alginate-gelatin-Matrigel hydrogels enable the development and multigenerational passaging of patient-derived 3D bioprinted cancer spheroid models
    Flores-Torres, Salvador
    Peza-Chavez, Omar
    Kuasne, Hellen
    Munguia-Lopez, Jose G.
    Kort-Mascort, Jacqueline
    Ferri, Lorenzo
    Jiang, Tao
    Rajadurai, Charles, V
    Park, Morag
    Sangwan, Veena
    Kinsella, Joseph M.
    BIOFABRICATION, 2021, 13 (02)
  • [43] In vitro drug screening of patient-derived 3D tumoroids replicates resistance to FOLFOX, FOLFIRI, and FOLFOXIRI in clinically resistant patients with metastatic colorectal cancer
    Hagel, G.
    Thastrup, O.
    Rafaelsen, S.
    Thastrup, J.
    Lindebjerg, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S339 - S339
  • [44] Time-lapse analysis of drug response and invasive capacity using patient-derived CRC microfluidic 3D cancer models under oxygen-controlled conditions
    Sabino, Dora
    Fixe, Isabelle
    Foucher, Alexandra
    Mennesson, Eric
    Normand, Nadia
    CANCER RESEARCH, 2018, 78 (13)
  • [45] Establishment of a 3D Co-culture With MDA-MB-231 Breast Cancer Cell Line and Patient-Derived Immune Cells for Application in the Development of Immunotherapies
    Saraiva, Diana P.
    Matias, Ana T.
    Braga, Sofia
    Jacinto, Antonio
    Cabral, M. Guadalupe
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [46] DEVELOPMENT OF A FUNCTIONAL PLATFORM FOR REAL-TIME PERSONALIZED DRUG SENSITIVITY PROFILING OF PATIENT-DERIVED 3D FRESH TUMOR TISSUE CULTURES IN THE PEDIATRIC PRECISION ONCOLOGY PROGRAM INFORM
    Peterziel, Heike
    Jamaladdin, Nora
    El Harouni, Dina
    Gerloff, Xenia F.
    Herter, Sonja
    Fiesel, Petra
    Berker, Yannick
    Blattner-Johnson, Mirjam
    Schramm, Kathrin
    Jones, Barbara C.
    Reuss, David
    Turunen, Laura
    Friedenauer, Aileen
    Holland-Letz, Tim
    Sill, Martin
    Weiser, Lena
    Previti, Christopher
    Ubramanian, Gnanaprakash Balas
    Gerber, Nicolas U.
    Gojo, Johannes
    Hutter, Caroline
    Ora, Ingrid
    Lohi, Olli
    Kattamis, Antonis
    De Wilde, Bram
    Termann, Frank Wes
    Tippelt, Stephan
    Graf, Norbert
    Nathrath, Michaela
    Sparber-Sauer, Monika
    Sehested, Astrid
    Kramm, Christof M.
    Dirksen, Uta
    Kallioniemi, Olli
    Pfister, Stefan M.
    Van Tilburg, Cornelis M.
    Jones, David T. W.
    Saarela, Jani
    Pietiainen, Vilja
    Jager, Natalie
    Schlesner, Matthias
    Kopp-Schneider, Annette
    Oppermann, Sina
    Milde, Till
    Witt, Olaf
    Oehme, Ina
    NEURO-ONCOLOGY, 2023, 25
  • [47] Generation of drug response data from 57 new patient-derived colon cancer xenografts and 3D cell cultures for systematic correlation with tumor biology within the OncoTrack* project
    Rivera, Maria
    Keil, Marlen
    Boehnke, Karsten
    Lange, Martin
    Schumacher, Dirk
    Schaefer, Reinhold
    Regenbrecht, Christian R.
    Henderson, David
    Keilholz, Ulrich
    Kuehn, Alexander
    El-Heliebi, Amin
    Hohensee, Tabea
    Haybaeck, Johannes
    Reinhard, Christoph
    Velasco, Juan A.
    Lehrach, Hans
    Garin-Chesa, Pilar
    Beran, Garry
    Hoffmann, Jens
    CANCER RESEARCH, 2014, 74 (19)
  • [48] GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids
    Bock, Nathalie
    Forouz, Farzaneh
    Hipwood, Luke
    Clegg, Julien
    Jeffery, Penny
    Gough, Madeline
    van Wyngaard, Tirsa
    Pyke, Christopher
    Adams, Mark N.
    Bray, Laura J.
    Croft, Laura
    Thompson, Erik W.
    Kryza, Thomas
    Meinert, Christoph
    PHARMACEUTICS, 2023, 15 (01)
  • [49] Development of patient-derived xenograft tumor models and 3D spheroid culture from advanced hormone receptor-positive inflammatory breast cancer patients for evaluation of new therapeutics
    Qiang, Wenan
    Zhong, Zhangfeng
    Monahan, Pamela
    Tse, Kristy
    Zhang, Youbin
    Zhang, Qiang
    Gerratana, Lorenzo
    Davis, Andrew
    Gursel, Demirkan
    Bleher, Reiner
    Wei, Jian-Jun
    James, Charles D.
    O'Halloran, Thomas V.
    Cristofanilli, Massimo
    CANCER RESEARCH, 2020, 80 (04)
  • [50] The antitumor activity of osimertinib plus palbociclib in non-small cell lung cancer patient-derived xenograft (PDX)/2D/3D culture models harboring EGFR amplification and CDKN2A/2B homozygous deletions
    Fu, Jen-Fen
    Hsu, Cheng-Lung
    Hsu, Ping-Chih
    NEOPLASIA, 2024, 57